August 11, 2023
The BioKansas Innovation Festival is a one‑day life‑sciences gathering at the Overland Park Convention Center. The event pairs conference sessions with a judged startup pitch competition and community STEM experiences. According to an event listing, the festival brings together students, professionals and life‑science experts to explore opportunities and innovations in the Kansas and Midwest bioscience ecosystem. It intentionally cross‑pollinates talks and panels during the day with a pitch competition anchored by industry judges in the afternoon and even hosts a “Brewseum” that celebrates the science of fermentation as part of the community programming.
Vivifi took the stage in 2023 and captured the Health Tech Pitch. The outcome was more than a ribbon—it widened our Midwestern network of clinicians, operators and potential manufacturing partners. Those relationships create optionality for multi‑site studies and future scale‑up outside the coasts. Winning at BioKansas validated our technology in a region known for its life‑science talent and offered connections that will inform our clinical and commercial strategy.
BioKansas is a nonprofit organization that supports the bioscience industry in Kansas and the surrounding region. The Innovation Festival is a one‑day scientific conference and community celebration that brings together students, professionals and experts to explore the region’s bioscience innovations. The festival features conference sessions, a startup pitch competition and interactive experiences that foster collaboration across academia, industry and the public.
Vivifi Medical is developing a function‑preserving solution for benign prostatic hyperplasia (BPH). By replumbing the prostate’s vasculature instead of removing tissue, our technology aims to restore normal urinary function without compromising quality of life. Success at the BioKansas Innovation Festival highlighted the cross‑regional appeal of our approach and introduced us to partners eager to participate in future studies.